The global prostate cancer therapeutics market is witnessing robust expansion, driven by rising disease prevalence, technological breakthroughs in oncology, and increasing investments in precision medicine. Valued at USD 13.21 billion in 2024, the market is projected to grow to USD 27.55 billion by 2033, registering a CAGR of 8.51% during 2025–2033.
Rising Disease Burden...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek